Gene · 1760
Papers3,275
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 3,275
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CAG repeat expansions create splicing acceptor sites and produce aberrant repeat-containing RNAs. | bioRxiv | 2023 | 37904984 | PubTator, text mining | PubMed |
| Unlocking the Complexity of Neuromuscular Diseases: Insights from Human Pluripotent Stem Cell-Derived Neuromuscular Junctions. | Int J Mol Sci | 2023 | 37894969 | PubTator, text mining | PubMed |
| Formation, function, and pathology of RNP granules. | Cell | 2023 | 37890457 | PubTator, text mining | PubMed |
| Modulatory role of RNA helicases in MBNL-dependent alternative splicing regulation. | Cell Mol Life Sci | 2023 | 37882878 | PubTator, text mining | PubMed |
| A deep population reference panel of tandem repeat variation. | Nat Commun | 2023 | 37872149 | PubTator, text mining | PubMed |
| Generation of induced pluripotent stem cell lines from pediatric patients with congenital myotonic dystrophy (CBRCULi012-A and CBRCULi013-A) and age-matched controls (CBRCULi010-A and CBRCULi011-A) | Stem Cell Res | 2023 | 37871474 | PubTator, text mining | PubMed |
| Genetic modifiers of repeat expansion disorders. | Emerg Top Life Sci | 2023 | 37861103 | PubTator, text mining | PubMed |
| A clinical evaluation of an ex vivo organ culture system to predict patient response to cancer therapy. | Front Med (Lausanne) | 2023 | 37840996 | PubTator, text mining | PubMed |
| Clinical interpretation of cell-based non-invasive prenatal testing for monogenic disorders including repeat expansion disorders: potentials and pitfalls. | Front Genet | 2023 | 37829280 | PubTator, text mining | PubMed |
| Male infertility with muscle weakness: a point of view. | Ann Med Surg (Lond) | 2023 | 37811075 | PubTator, text mining | PubMed |
| A two-cohort study on the association between the gut microbiota and bone density, microarchitecture, and strength. | Front Endocrinol (Lausanne) | 2023 | 37810879 | PubTator, text mining | PubMed |
| Cardiac involvement in patient-specific induced pluripotent stem cells of myotonic dystrophy type 1: unveiling the impact of voltage-gated sodium channels. | Front Physiol | 2023 | 37791351 | PubTator, text mining | PubMed |
| Application of Advanced Technologies-Nanotechnology, Genomics Technology, and 3D Printing Technology-In Precision Anesthesia: A Comprehensive Narrative Review. | Pharmaceutics | 2023 | 37765258 | PubTator, text mining | PubMed |
| Diagnosis and Management of Seronegative Myasthenia Gravis: Lights and Shadows. | Brain Sci | 2023 | 37759888 | PubTator, text mining | PubMed |
| Insight and Recommendations for Fragile X-Premutation-Associated Conditions from the Fifth International Conference on FMR1 Premutation. | Cells | 2023 | 37759552 | PubTator, text mining | PubMed |
| Functional characterization of a single nucleotide polymorphism associated with Alzheimer's disease in a hiPSC-based neuron model. | PLoS One | 2023 | 37751459 | PubTator, text mining | PubMed |
| A curated census of pathogenic and likely pathogenic UTR variants and evaluation of deep learning models for variant effect prediction. | Front Mol Biosci | 2023 | 37745687 | PubTator, text mining | PubMed |
| Undiagnosed myotonic dystrophy: A case report and literature review. | Med Int (Lond) | 2023 | 37745151 | PubTator, text mining | PubMed |
| Peptide-conjugated antimiRs improve myotonic dystrophy type 1 phenotypes by promoting endogenous MBNL1 expression. | Mol Ther Nucleic Acids | 2023 | 37744174 | PubTator, text mining | PubMed |
| Direct decarboxylative Giese amidations: photocatalytic vs. metal- and light-free. | Chem Sci | 2023 | 37736650 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1760/papers?page=12